Establishment profile
TEVA PHARMACEUTICALS USA
1090 HORSHAM ROAD, NORTH WALES, PA, 19454
Operated by TEVA PHARMACEUTICAL INDUSTRIES LTD · 1 of 29 establishments
325412 — Pharmaceutical Preparation Manufacturing
EIN 221734359
Summary
TEVA PHARMACEUTICALS USA has accumulated 0 OSHA violations across 1 inspection over 11 years of recorded history.
The most recent federal enforcement activity was recorded 11 years ago.
Federal records were found in 2 of 15 sources. Sources without matching records returned empty for this establishment.
Agency coverage
TEVA PHARMACEUTICALS USA appears in OSHA workplace safety and UVA Corporate Prosecution Registry records only. No matching records were found in WHD wage enforcement, MSHA mine safety, EPA environmental compliance, NLRB labor relations, OFLC visa and labor certification (historical), FMCSA motor carrier registration, SAM.gov federal debarment, CMS nursing home enforcement, CPSC product recalls, or NHTSA vehicle recalls.
OSHA workplace safety
Peer comparison
Fewer violations than most other employers in NAICS 3254 within PA. Peer group: 93 employers. This establishment has 0 OSHA violations; peer median is 0.
Safety self-report (OSHA 300A)
Recordable injury rates the employer filed with OSHA’s Injury Tracking Application. DART covers cases with days away, restricted, or transferred; TRIR is the total recordable case rate.
Reported for 24 average annual employees at this establishment.
Source: OSHA ITA Form 300A (employer self-reported). Rates are per 100 full-time equivalent workers. Establishments below the ~10-FTE threshold are not required to report.
Industry benchmark
BLS rates reflect industry-wide averages. Self-reported figures come from OSHA’s Injury Tracking Application; absence of self-reported data does not necessarily indicate non-compliance — many establishments fall below the ITA reporting threshold.
Inspection breakdown
Complaint- and accident-triggered inspections are stronger risk signals than routine planned inspections.
OSHA severe injury reports
No severe injury reports (hospitalization, amputation, or loss of an eye) on file under 29 CFR 1904.39 for TEVA PHARMACEUTICALS USA. Verify directly with Occupational Safety and Health Administration →
Activity timeline
No federal enforcement activity has been recorded against this establishment in 11+ years. Most recent activity: 11 years ago. Data on this page is refreshed weekly.
Wage & Hour Division (WHD)
No WHD wage, overtime, or child-labor enforcement cases on file for TEVA PHARMACEUTICALS USA. Verify directly with Wage and Hour Division →
Mine safety (MSHA)
No MSHA mine safety violations on file for TEVA PHARMACEUTICALS USA. Verify directly with Mine Safety and Health Administration →
Labor relations (NLRB)
No NLRB unfair labor practice charges or union representation cases on file for TEVA PHARMACEUTICALS USA. Verify directly with National Labor Relations Board →
Visa & labor certification (OFLC) — historical
No H-1B, H-2A, or H-2B labor condition applications on file (historical data only — DOL ended OFLC publication) for TEVA PHARMACEUTICALS USA. Verify directly with Office of Foreign Labor Certification →
Environmental compliance (EPA)
No EPA inspections or formal enforcement actions on file for TEVA PHARMACEUTICALS USA. Verify directly with Environmental Protection Agency →
Federal criminal prosecution record
First case: 2023-08-21. Most recent: 2023-08-21. Source: UVA Corporate Prosecution Registry — federal pleas, DPAs, and NPAs.
Federal prosecution case file
Federal corporate prosecution records from the University of Virginia Corporate Prosecution Registry. DPA = Deferred Prosecution Agreement; NPA = Non-Prosecution Agreement; both are pre-trial settlements where the defendant accepts terms but avoids conviction. Monitor = court-appointed compliance oversight, usually 2-5 years. 1 case · $225,000,000 in penalties / restitution.
| Case | Date | Disposition | Crime | Jurisdiction | Total payment | Monitor |
|---|---|---|---|---|---|---|
Teva Pharmaceuticals USA, Inc. | Aug 2023 | DP | Antitrust | USDOJ - Antitrust Division | $225,000,000 | No |
Source: University of Virginia Corporate Prosecution Registry (maintained by Prof. Brandon L. Garrett, Duke University). The registry has no state or jurisdiction-of-incorporation field on the company side, so same-name employers in different states may mis-attribute -- verify against the source case documents when precision matters.
Federal contracts
This location
Consolidated across all USAspending recipient entities under this corporate parent — not attributable to this single location.
- Department of Defense8511147946!ADENOVIRUS TYPE 4 Acontract · Last action 2025-01-28$5,285,022
- Department of Defense8511856699!ADENOVIRUS TYPE 4 Acontract · Last action 2026-01-13$3,950,554
- Department of Defense8511009796!ADENOVIRUS TYPE 4 Acontract · Last action 2024-11-14$3,176,095
- Department of Defense8510325537!ADENOVIRUS TYPE 4 Acontract · Last action 2023-12-14$2,443,150
- Department of Defensecontract · Last action 2017-02-17$2,269,470
- Department of Defense8511784063!ADENOVIRUS TYPE 4 Acontract · Last action 2025-12-01$1,981,883
- Department of Defense8510559015!ADENOVIRUS TYPE 4 Acontract · Last action 2024-04-09$1,588,047
- Department of Defense8510325475!ADENOVIRUS TYPE 4 Acontract · Last action 2023-12-14$1,526,969
- Department of Defense8510766857!ADENOVIRUS TYPE 4 Acontract · Last action 2024-07-19$1,429,243
- Department of Defense8510688482!ADENOVIRUS TYPE 4 Acontract · Last action 2024-06-13$1,429,243
- Department of Defense8510634433!ADENOVIRUS TYPE 4 Acontract · Last action 2024-05-15$1,429,243
- Department of Defense8507666472!ADENOVIRUS TYPE 4 Acontract · Last action 2020-09-21$1,357,470
- Department of Defense8507666398!ADENOVIRUS TYPE 4 Acontract · Last action 2020-09-21$1,357,470
- Department of Defense8511784064!ADENOVIRUS TYPE 4 Acontract · Last action 2025-12-01$1,321,255
- Department of Defense8510902080!ADENOVIRUS TYPE 4 Acontract · Last action 2024-09-18$1,270,438
- Department of Defense8510401601!ADENOVIRUS TYPE 4 Acontract · Last action 2024-01-25$1,270,438
- Department of Defense8507666399!ADENOVIRUS TYPE 4 Acontract · Last action 2020-09-21$1,221,723
- Department of Defense8507153551!ADENOVIRUS TYPE 4 Acontract · Last action 2020-02-07$1,221,723
- Department of Defense8511565495!ADENOVIRUS TYPE 4 Acontract · Last action 2025-08-12$1,156,099
- Department of Defense8511148052!ADENOVIRUS TYPE 4 Acontract · Last action 2025-01-28$1,156,099
- Department of Defense8510839749!ADENOVIRUS TYPE 4 Acontract · Last action 2024-08-22$1,111,633
- Department of Defense8510500489!ADENOVIRUS TYPE 4 Acontract · Last action 2024-03-13$1,111,633
- Department of Defense8507153570!ADENOVIRUS TYPE 4 Acontract · Last action 2020-02-07$1,085,976
- Department of Defense8509568637!ADENOVIRUS TYPE 4 Acontract · Last action 2022-12-06$1,027,768
- Department of Defense8509567884!ADENOVIRUS TYPE 4 Acontract · Last action 2022-12-06$1,027,768
- Department of Defense8511369471!ADENOVIRUS TYPE 4 Acontract · Last action 2025-05-12$990,942
- Department of Defense8511296118!ADENOVIRUS TYPE 4 Acontract · Last action 2025-04-07$990,942
- Department of Defense8511229343!ADENOVIRUS TYPE 4 Acontract · Last action 2025-03-06$990,942
- Department of Defense8508275916!ADENOVIRUS TYPE 4 Acontract · Last action 2021-06-08$988,238
- Department of Defense8510462163!ADENOVIRUS TYPE 4 Acontract · Last action 2024-02-22$952,828
- Department of Defense8507666471!ADENOVIRUS TYPE 4 Acontract · Last action 2020-09-21$950,229
- Department of Defense8507538016!ADENOVIRUS TYPE 4 Acontract · Last action 2020-07-22$950,229
- Department of Defense8507395371!ADENOVIRUS TYPE 4 Acontract · Last action 2020-05-21$950,229
- Department of Defense8507153556!ADENOVIRUS TYPE 4 Acontract · Last action 2020-02-07$950,229
- Department of Defense8510325476!ADENOVIRUS TYPE 4 Acontract · Last action 2023-12-14$916,181
- Department of Defense8510093039!ADENOVIRUS TYPE 4 Acontract · Last action 2023-08-22$916,181
- Department of Defense8510016515!ADENOVIRUS TYPE 4 Acontract · Last action 2023-07-18$916,181
- Department of Defense8510016965!ADENOVIRUS TYPE 4 Acontract · Last action 2023-07-18$916,181
- Department of Defense8509963743!ADENOVIRUS TYPE 4 Acontract · Last action 2023-06-20$916,181
- Department of Defense8508509762!ADENOVIRUS TYPE 4 Acontract · Last action 2021-09-09$847,061
- Department of Defense8508432581!ADENOVIRUS TYPE 4 Acontract · Last action 2021-08-11$847,061
- Department of Defense8508191759!ADENOVIRUS TYPE 4 Acontract · Last action 2021-05-06$847,061
- Department of Defense8511624235!ADENOVIRUS TYPE 4 Acontract · Last action 2025-09-08$825,785
- Department of Defense8511624191!ADENOVIRUS TYPE 4 Acontract · Last action 2025-09-08$825,785
- Department of Defense8511624231!ADENOVIRUS TYPE 4 Acontract · Last action 2025-09-08$825,785
- Department of Defense8511565494!ADENOVIRUS TYPE 4 Acontract · Last action 2025-08-12$825,785
- Department of Defense8511499274!ADENOVIRUS TYPE 4 Acontract · Last action 2025-07-14$825,785
- Department of Defense8511499119!ADENOVIRUS TYPE 4 Acontract · Last action 2025-07-14$825,785
- Department of Defense8511499116!ADENOVIRUS TYPE 4 Acontract · Last action 2025-07-14$825,785
- Department of Defense8511446666!ADENOVIRUS TYPE 4 Acontract · Last action 2025-06-16$825,785
Federal contract dollars to this establishment. Primary NAICS: 325412 - PHARMACEUTICAL PREPARATION MANUFACTURING. Last action: 2026-04-10. Source: USAspending.gov, net obligations. Recipient address is the SAM registration / HQ address, not necessarily the worksite.
Inspection history
| Date | Trigger | Violations | Serious | Penalty | |
|---|---|---|---|---|---|
| 2015-07-09 | Planned | 0 | — | $0 |
Source: OSHA IMIS. Citation amounts reflect initially assessed penalties; final amounts after appeal may differ.
In the news
Part of a larger organization
TEVA PHARMACEUTICALS USA is one of 29 establishments rolled up under the parent organization TEVA PHARMACEUTICAL INDUSTRIES LTD.
Federal enforcement records on this page represent activity at this specific establishment only. The full enforcement footprint of TEVA PHARMACEUTICAL INDUSTRIES LTD across all 29 of its tracked locations is viewable on the parent profile.
Other employers in this industry and state
Other employers in pharmaceutical preparation manufacturing within PA, ordered by federal enforcement volume:
- KVK TECH, INC.NEWTOWN — 3 federal enforcement records
- MERCK & CO., INC.WEST POINT — 3 federal enforcement records
- MERCK SHARP & DOHME, LLCWEST POINT — 2 federal enforcement records
- BAYER HEALTHCARE LLCMYERSTOWN — 2 federal enforcement records
- JOHNSON MATTHEY INC.CONSHOHOCKEN — 2 federal enforcement records
- BIOSPECTRA, INC.BANGOR — 2 federal enforcement records
- COPPERHEAD CHEMICAL COMPANY, INC.TAMAQUA — 2 federal enforcement records
- SANOFI PASTEURSWIFTWATER — 1 federal enforcement record
- PENN AH ORGANICSLEMONT FURNACE — 1 federal enforcement record
- CATALENT PHARMA SOLUTIONS, LLCPHILADELPHIA — 1 federal enforcement record
Other locations under this parent
Other establishments operated by TEVA PHARMACEUTICAL INDUSTRIES LTD, ordered by federal enforcement volume:
- TEVA PHARMACEUTICALS USA INCFAIRFIELD, NJ — 2 federal enforcement records
- ARROW INTERNATIONAL, INC.MT. HOLLY, NJ — 2 federal enforcement records
- ARROW INTERNATIONAL INCORPORATCleveland, OH — 1 federal enforcement record
- TEVA PHARMACEUTICALS USA, INC.MIAMI, FL — 1 federal enforcement record
- ARROW INTERNATIONAL, INC.BROOKLYN, OH — 1 federal enforcement record
- ARROW INTERNATIONAL, INCORPORATEDREADING, PA — 1 federal enforcement record
- ARROW INTERNATIONALRANDLEMAN, NC — 1 federal enforcement record
- ARROW INTERNATIONAL INC MEDICAL DIVISIONASHEBORO, NC — 1 federal enforcement record
- ARROW INTERNATIONAL INCOSSEO, MN — 1 federal enforcement record
- ARROW INTERNATIONAL INCLYNNWOOD, WA — 1 federal enforcement record
Related searches
- All TEVA PHARMACEUTICAL INDUSTRIES LTD locationsParent rollup
- Pharmaceutical Preparation ManufacturingAll employers in this industry
- Employers in PAState-wide enforcement data
- Pharmaceutical Preparation Manufacturing in PAIndustry × state cross-filter
About this data
This profile aggregates federal enforcement records on TEVA PHARMACEUTICALS USA from every major federal compliance and enforcement source plus the UVA Corporate Prosecution Registry. OSHA workplace safety inspections, WHD wage cases, MSHA mine safety, EPA environmental enforcement, NLRB labor relations, OFLC visa/labor certification, FMCSA motor carrier registration, SAM.gov debarments, CMS nursing-home records, BLS industry safety benchmarks, OSHA ITA self-reported injury rates, SEC enforcement and financial disclosures, CPSC and NHTSA recalls.
Establishments are matched across agencies using normalized employer name, state, and ZIP code. This establishment resolves to the parent rollup TEVA PHARMACEUTICAL INDUSTRIES LTD, which operates 29 establishments in our dataset.
OSHA citations typically appear 3–8 months after the inspection, so very recent enforcement actions may not yet be reflected. Profiles may be incomplete if the establishment operates under multiple legal names or files under variations our entity-matching rules don’t yet cover. To report a missing record or correction, email corrections@fastdol.com.
Need API access, bulk download, or licensed redistribution? The website is free. Programmatic and licensed access is handled separately.
Contact sales →Frequently asked
- What is TEVA PHARMACEUTICALS USA's OSHA violation history?
- TEVA PHARMACEUTICALS USA has 1 OSHA inspection on record with 0 violations and $0 in total penalties.
- How does TEVA PHARMACEUTICALS USA's safety record compare to its industry?
- TEVA PHARMACEUTICALS USA operates in the pharmaceutical preparation manufacturing industry. The industry average Total Recordable Incident Rate (TRIR) is 1.4. TEVA PHARMACEUTICALS USA's self-reported DART rate is 0 compared to an industry average of 0.9.